Title The Clinical value of adipokines in predicting the severity and outcome of acute pancreatitis /
Authors Karpavičius, Andrius ; Dambrauskas, Žilvinas ; Gradauskas, Audrius ; Samuilis, Artūras ; Žvinienė, Kristina ; Kupčinskas, Juozas ; Brimas, Gintautas ; Mečkovski, Artur ; Šileikis, Audrius ; Strupas, Kęstutis
DOI 10.1186/s12876-016-0514-4
Full Text Download
Is Part of BMC gastroenterology.. London : BioMed Central. 2016, vol. 16, no. 1, p. 1-8.. ISSN 1471-230X
Keywords [eng] Pancreatitis ; Acute disease ; Adipokines ; Prognosis
Abstract [eng] BACKGROUND: Recent data shows that patients with severe acute pancreatic might benefit from early intensive therapy, enteral nutrition and timely transfer to specialized centers. The early prophylactic use of antibiotics in AP remains controversial. The role and need for new markers in stratification of acute pancreatitis is also uncertain. This study aims to evaluate the prognostic usefulness of adipokines in prediction of the severity and outcome of acute pancreatitis (AP). METHODS: Prospective study was conducted in four clinical centers. The diagnosis and severity assessment of AP was established according to the revised 2012 Atlanta classification. Adipokines, IL-6 and CRP levels were measured at admission and on 3rd day of hospital stay and compared with the control group. The predictive accuracy of each marker was measured by area under the receiver operating curve. RESULTS: Forty healthy controls and 102 patients were enrolled in to the study. Twenty seven (26.5 %) patients had mild, 55 (53.9 %) - moderate and 20 (19.6 %) - severe AP. Only resistin (cut-off value 13.7 ng/ml) and IL-6 (cut-off value 473.4 pg/ml) were reliable early markers of SAP. IL-6 with cut-off value of 157.0 pg/ml was a predictor of necrosis. The peripancreatic necrosis volume of 112.5 ml was a marker of SAP and 433.0 ml cut-off value could be used to predict the need of interventions. CONCLUSIONS: The prognostic value of adipokines in AP is limited. Only admission resistin levels could serve as an early predictor for SAP. The Lithuanian Regional Ethics Committee approved the study protocol (permission No. L-12-02/1/2/3/4) and all the patients and the control group provided written informed consent.
Published London : BioMed Central
Type Journal article
Language English
Publication date 2016
CC license CC license description